Assessing and Advancing Progress in the Delivery of High-Quality Cancer Care: Proceedings of a Workshop (2024)
Chapter: Front Matter
Assessing and Advancing
Progress in the Delivery of
High-Quality Cancer Care
_____
Co-hosted by the American Society of
Clinical Oncology and the
National Cancer Policy Forum
Erin Balogh, Theresa Wizemann,
and Sharyl Nass, Rapporteurs
National Cancer Policy Forum
Board on Health Care Services
Health and Medicine Division
Proceedings of a Workshop
NATIONAL ACADEMIES PRESS 500 Fifth Street, NW, Washington, DC 20001
This activity was supported by Contract No. 75D30121D11240 (Task Order Nos. 75D30121F00002 and 75D30123F00024) and Contract No. HHSN263 201800029I (Task Order Nos. HHSN26300008 and 75N98023F00019) with the Centers for Disease Control and Prevention and the National Cancer Institute/National Institutes of Health, respectively, and by the American Association for Cancer Research; American Cancer Society; American College of Radiology; American Society of Clinical Oncology; Association of American Cancer Institutes; Association of Community Cancer Centers; Flatiron Health; Merck & Co., Inc.; National Comprehensive Cancer Network; National Patient Advocate Foundation; Novartis Oncology; Oncology Nursing Society; Partners in Health; and Pfizer Inc. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
International Standard Book Number-13: 978-0-309-71941-4
International Standard Book Number-10: 0-309-71941-0
Digital Object Identifier: https://doi.org/10.17226/27779
Epub ISBN: 978-0-309-71944-5
This publication is available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Copyright 2024 by the National Academy of Sciences. National Academies of Sciences, Engineering, and Medicine and National Academies Press and the graphical logos for each are all trademarks of the National Academies of Sciences. All rights reserved.
Printed in the United States of America
Suggested citation: National Academies of Sciences, Engineering, and Medicine. 2024. Assessing and advancing progress in the delivery of high-quality cancer care: Proceedings of a workshop. Washington, DC: The National Academies Press. https://doi.org/10.17226/27779.
The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Marcia McNutt is president.
The National Academy of Engineering was established in 1964 under the charter of the National Academy of Sciences to bring the practices of engineering to advising the nation. Members are elected by their peers for extraordinary contributions to engineering. Dr. John L. Anderson is president.
The National Academy of Medicine (formerly the Institute of Medicine) was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distinguished contributions to medicine and health. Dr. Victor J. Dzau is president.
The three Academies work together as the National Academies of Sciences, Engineering, and Medicine to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine.
Learn more about the National Academies of Sciences, Engineering, and Medicine at www.nationalacademies.org.
Consensus Study Reports published by the National Academies of Sciences, Engineering, and Medicine document the evidence-based consensus on the study’s statement of task by an authoring committee of experts. Reports typically include findings, conclusions, and recommendations based on information gathered by the committee and the committee’s deliberations. Each report has been subjected to a rigorous and independent peer-review process and it represents the position of the National Academies on the statement of task.
Proceedings published by the National Academies of Sciences, Engineering, and Medicine chronicle the presentations and discussions at a workshop, symposium, or other event convened by the National Academies. The statements and opinions contained in proceedings are those of the participants and are not endorsed by other participants, the planning committee, or the National Academies.
Rapid Expert Consultations published by the National Academies of Sciences, Engineering, and Medicine are authored by subject-matter experts on narrowly focused topics that can be supported by a body of evidence. The discussions contained in rapid expert consultations are considered those of the authors and do not contain policy recommendations. Rapid expert consultations are reviewed by the institution before release.
For information about other products and activities of the National Academies, please visit www.nationalacademies.org/about/whatwedo.
PLANNING COMMITTEE1
PATRICIA GANZ (Chair), University of California, Los Angeles
JUSTIN BEKELMAN, University of Pennsylvania
NARJUST FLOREZ, Dana-Farber Cancer Institute
CHRISTOPHER R. FRIESE, University of Michigan
CAROLYN HENDRICKS, Maryland Oncology Hematology
HEDVIG HRICAK, Memorial Sloan Kettering Cancer Center
LARISSA NEKHLYUDOV, Brigham and Women’s Hospital and Dana-Farber Cancer Institute
LAUREL PRACHT, West Valley Ovarian Cancer Alliance
NATHAN PENNELL, Cleveland Clinic
CARDINALE SMITH, Mount Sinai Health System
ISHWARIA SUBBIAH, Sarah Cannon Research Institute
ROBIN YABROFF, American Cancer Society
Project Staff
ANNA ADLER, Senior Program Assistant
TORRIE BROWN, Program Coordinator
CHIDINMA CHUKWURAH, Senior Program Assistant (until April 2024)
EMMA WICKLAND, Research Associate
JULIE WILTSHIRE, Senior Finance Business Partner
JENNIFER ZHU, Associate Program Officer
ERIN BALOGH, Co-Director, National Cancer Policy Forum (until June 2024)
LAURENE GRAIG, Senior Program Officer (June–July 2024)
FRANCIS AMANKWAH, Co-Director, National Cancer Policy Forum (from July 2024)
SHARYL NASS, Co-Director, National Cancer Policy Forum; Senior Director, Board on Health Care Services
___________________
1 The National Academies of Sciences, Engineering, and Medicine’s planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for the published Proceedings of a Workshop rests with the workshop rapporteurs and the institution.
NATIONAL CANCER POLICY FORUM2
ROBERT A. WINN (Chair), Virginia Commonwealth University
JUSTIN E. BEKELMAN, University of Pennsylvania
SMITA BHATIA, The University of Alabama at Birmingham
GIDEON BLUMENTHAL, Merck
CHRIS BOSHOFF, Pfizer Inc.
OTIS W. BRAWLEY, Johns Hopkins University
CHRISTINA CHAPMAN, Baylor College of Medicine; Michael E. DeBakey VA Medical Center
GWEN DARIEN, National Patient Advocate Foundation
CRYSTAL DENLINGER, National Comprehensive Cancer Network
JAMES H. DOROSHOW, National Cancer Institute
S. GAIL ECKHARDT, Baylor College of Medicine
CHRISTOPHER R. FRIESE, University of Michigan
STANTON L. GERSON, Case Western Reserve University
SCARLETT LIN GOMEZ, University of California, San Francisco
JULIE R. GRALOW, American Society of Clinical Oncology
ROY S. HERBST, Yale University; American Association for Cancer Research
HEDVIG HRICAK, Memorial Sloan Kettering Cancer Center
CHANITA HUGHES-HALBERT, University of Southern California
ROY A. JENSEN, University of Kansas; Association of American Cancer Institutes
RANDY A. JONES, University of Virginia
BETH Y. KARLAN, University of California, Los Angeles
SAMIR N. KHLEIF, Georgetown University; Society for Immunotherapy of Cancer
SCOTT M. LIPPMAN, University of California, San Diego
ELENA MARTINEZ, University of California, San Diego
LARISSA NEKHLYUDOV, Brigham and Women’s Hospital; Dana-Farber Cancer Institute; Harvard Medical School
RANDALL A. OYER, University of Pennsylvania; Penn Medicine Lancaster General Health; Association of Community Cancer Centers
CLEO A. RYALS, Flatiron Health
RICHARD L. SCHILSKY, ASCO TAPUR Study; University of Chicago
JULIE SCHNEIDER, Oncology Center of Excellence, U.S. Food and Drug Administration
___________________
2 The National Academies of Sciences, Engineering, and Medicine’s forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published Proceedings of a Workshop rests with the workshop rapporteurs and the institution.
SUSAN M. SCHNEIDER, Duke University
LAWRENCE N. SHULMAN, University of Pennsylvania
HEIDI SMITH, Novartis Pharmaceuticals
KATRINA TRIVERS, Centers for Disease Control and Prevention
ROBIN YABROFF, American Cancer Society
Forum Staff
ANNA ADLER, Senior Program Assistant
TORRIE BROWN, Program Coordinator
EMMA WICKLAND, Research Associate
CHIDINMA CHUKWURAH, Senior Program Assistant (until April 2024)
JULIE WILTSHIRE, Senior Finance Business Partner
JENNIFER ZHU, Associate Program Officer
ERIN BALOGH, Co-Director, National Cancer Policy Forum (until June 2024)
LAURENE GRAIG, Senior Program Officer (June–July 2024)
FRANCIS AMANKWAH, Co-Director, National Cancer Policy Forum (from July 2024)
SHARYL NASS, Co-Director, National Cancer Policy Forum; Senior Director, Board on Health Care Services
This page intentionally left blank.
Reviewers
This Proceedings of a Workshop was reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise. The purpose of this independent review is to provide candid and critical comments that will assist the National Academies of Sciences, Engineering, and Medicine in making each published proceedings as sound as possible and to ensure that it meets the institutional standards for quality, objectivity, evidence, and responsiveness to the charge. The review comments and draft manuscript remain confidential to protect the integrity of the process.
We thank the following individuals for their review of this report:
HEIDI KLEPIN, Wake Forest University School of Medicine
NANCY KEATING, Harvard Medical School
JULIA ROWLAND, Smith Center for Healing and the Arts
YA-CHEN TINA SHIH, UCLA David Geffen School of Medicine
Although the reviewers listed above provided many constructive comments and suggestions, they were not asked to endorse the conclusions or recommendations of this report nor did they see the final draft before its release. The review of this proceedings was overseen by BETTY FERRELL, City of Hope. She was responsible for making certain that an independent examination of this report was carried out in accordance with the standards of the National Academies and that all review comments were carefully considered. Responsibility for the final content rests entirely with the rapporteurs and the National Academies.
This page intentionally left blank.
Acknowledgments
The National Cancer Policy Forum is grateful for the support of our many annual sponsors. Federal sponsors include the Centers for Disease Control and Prevention and the National Cancer Institute/National Institutes of Health. Nonfederal sponsors include the American Association for Cancer Research; American Cancer Society; American College of Radiology; American Society of Clinical Oncology; Association of American Cancer Institutes; Association of Community Cancer Centers; Flatiron Health; Merck & Co., Inc.; National Comprehensive Cancer Network; National Patient Advocate Foundation; Novartis Oncology; Oncology Nursing Society; Partners in Health; and Pfizer Inc.
The forum wishes to express its gratitude to the expert speakers whose presentations and discussions identified opportunities to advance progress in the delivery of high-quality cancer care. The forum also wishes to thank the members of the planning committee for their work in developing an excellent workshop agenda.
This page intentionally left blank.
Contents
PROGRESS SINCE THE 2013 IOM REPORT
Overview of the 2013 Report Recommendations and Implementation Progress
Changes in the Landscape of Oncology Care Since 2013
ADVANCING THE CONTINUUM OF PATIENT-CENTERED CANCER CARE
The Changing Face of Cancer: Progress and Emerging Trends
Patient and Community Engagement
Developing the Infrastructure for Sustainable Models of Cancer Care Delivery
Delivering Equitable, High-Quality Cancer Care in the Veterans Health Administration
Delivering Psychosocial Care to Cancer Survivors
Sustainable Rural Cancer Care Models
WORKFORCE CONSIDERATIONS: REACHING FOR THE QUADRUPLE AIM
Multidisciplinary, Multispecialty Workforce from Diagnosis Onward
Taking a Systematic Approach to Oncology Workforce Wellness
Promoting and Sustaining Diversity in the Oncology Workforce
Continuing Education and Training
Opportunities to Leverage Digital Health to Improve System Efficiencies and Care
Improving Patient-Centered Care and Clinician Well-Being
Securing Funding and Leadership Support Needed for Improving Care
Developing a Learning Health System to Transform Care and Health Equity
Value-Based Payment and the Delivery of High-Quality and Equitable Cancer Care
Health Insurer Perspective on Cancer Care Delivery Transformation
Cancer Care Delivery in Community Practice
Primary Care and Specialty Care Integration
The Role of Clinical Trials in Cancer Care
EVIDENCE GENERATION TO INFORM ONCOLOGY CARE
Perspectives on Progress in Evidence Generation Since 2013
Health Disparities in Cancer Research and Patient Access to Cancer Care
Advancing Equitable Implementation of Evidence-Based Oncology Care
This page intentionally left blank.
Acronyms and Abbreviations
| AAMC | Association of American Medical Colleges |
| ACA | Affordable Care Act |
| ACCC | Association of Community Cancer Centers |
| ACS | American Cancer Society |
| AI | artificial intelligence |
| API | application programming interface |
| APP | advanced practice provider |
| ARPA-H | Advanced Research Projects Agency for Health |
| ASCO | American Society of Clinical Oncology |
| CDC | Centers for Disease Control and Prevention |
| CMS | Centers for Medicare & Medicaid Services |
| EGFR | epidermal growth factor receptor |
| EHR | electronic health record |
| EOM | Enhancing Oncology Model |
| FDA | U.S. Food and Drug Administration |
| FHIR® | Fast Healthcare Interoperability Resources® |
| HHS | U.S. Department of Health and Human Services |
| HIPAA | Health Insurance Portability and Accountability Act |
| HL7® | Health Level 7® |
| IOM | Institute of Medicine |
| IT | information technology |
| mCODE | Minimal Common Oncology Data Elements |
| MSK | Memorial Sloan Kettering Cancer Center |
| NCCS | National Coalition for Cancer Survivorship |
| NCI | National Cancer Institute |
| NPAF | National Patient Advocate Foundation |
| OCE | Oncology Center of Excellence |
| OCM | Oncology Care Model |
| PD-1 | programmed cell death protein 1 |
| PRO | patient-reported outcome |
| PROTEUS | Patient-Reported Outcomes Tools: Engaging Users and Stakeholders |
| ROI | return on investment |
| VHA | Veterans Health Administration |
